Medicare Enrolled

Dr. Varuna Nargunan, M.D

Endocrinology · Odessa, TX
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
315 GOLDER AVE, Odessa, TX 79761
4326403052
In practice since 2008 (17 years)
NPI: 1386807089 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Nargunan from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Nargunan? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Nargunan

Dr. Varuna Nargunan is an endocrinology specialist in Odessa, TX, with 17 years of NPI registration. Based on federal Medicare data, Dr. Nargunan performed 1,444 Medicare services across 695 unique beneficiaries.

Between the years covered by Open Payments, Dr. Nargunan received a total of $6,926 from 38 pharmaceutical and/or device companies across 348 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in endocrinology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Nargunan is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 17 years in practice ▲ Top 31% volume in TX $6,926 industry payments

Medicare Practice Summary

Medicare Utilization ↗
1,444
Medicare services
Top 31% in TX for endocrinology
695
Unique beneficiaries
$39
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~85 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Blood glucose (sugar) test performed by hand-held instrument 398 $3 $15
Office visit, established patient (30-39 min) 380 $89 $269
Hemoglobin A1c test (diabetes monitoring) 306 $9 $36
Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report 119 $26 $116
Office visit, established patient (20-29 min) 100 $57 $182
New patient office visit (45-59 min) 46 $119 $412
Influenza vaccine, quadrivalent, 0.5 ml dosage 25 $19 $22
Flu vaccine administration 25 $11 $11
Fine needle aspiration biopsy using ultrasound guidance, first growth 24 $99 $316
New patient office visit (30-44 min) 21 $80 $269
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$6,926
Total received (2018-2024)
Avg $989/year across 7 years
Top 39% in TX for endocrinology
38
Companies
348
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$6,900 (99.6%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$26 (0.4%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$884
2023
$653
2022
$875
2021
$949
2020
$875
2019
$768
2018
$1,921

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Medtronic MiniMed, Inc.
$1,222
AstraZeneca Pharmaceuticals LP
$969
Novo Nordisk Inc
$866
Lilly USA, LLC
$742
Boehringer Ingelheim Pharmaceuticals, Inc.
$671
Amgen Inc.
$447
Abbott Laboratories
$261
SANOFI-AVENTIS U.S. LLC
$250
Xeris Pharmaceuticals, Inc.
$208
Insulet Corporation
$170
Horizon Therapeutics plc
$132
MannKind Corporation
$113
Janssen Pharmaceuticals, Inc
$111
Astellas Pharma US Inc
$84
Tandem Diabetes Care, Inc.
$75
Merck Sharp & Dohme Corporation
$54
Amarin Pharma Inc.
$52
PFIZER INC.
$51
Eisai Inc.
$48
Radius Health, Inc.
$40
Corcept Therapeutics
$39
Kyowa Kirin, Inc.
$38
Amryt Pharma Holdings Ltd
$34
Sun Pharmaceutical Industries Inc.
$23
Novartis Pharmaceuticals Corporation
$22
IBSA Pharma Inc.
$22
Ultragenyx Pharmaceutical Inc.
$17
Bayer HealthCare Pharmaceuticals Inc.
$16
Bayer Healthcare Pharmaceuticals Inc.
$16
Dexcom, Inc.
$16
DEXCOM, INC.
$16
Medtronic, Inc.
$15
Esperion Therapeutics, Inc.
$15
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$14
SANOFI PASTEUR INC.
$14
Alexion Pharmaceuticals, Inc.
$14
Shire North American Group Inc
$14
AbbVie Inc.
$13
Top 3 companies account for 44.1% of total payments
Associated products mentioned in payments ›
ABSOLUTE PRO · AFREZZA · BAQSIMI · BASAGLAR · BYDUREON · Belviq · CHANTIX · Crysvita · DEXCOM CGM · DEXCOM G6 TRANSMITTER · Dayvigo · EVENITY · FARXIGA · FLUZONE HIGH-DOSE · FREESTYLE LIBRE · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · FreeStyle Libre · GVOKE HYPOPEN · GVOKE PFS · HUMULIN · INFUGEM · INVOKANA · JANUMET XR · JANUVIA · JARDIANCE · KEVEYIS · Kerendia · Korlym · LEQVIO · LINZESS · MINIMED 780G · MOUNJARO · MYCAPSSA · MYRBETRIQ · Minimed 530G · Minimed 670G System · NATPARA (PARATHYROID HORMONE) · NEXLETOL · Omnipod · Ozempic · PRALUENT · PROCLAIM · Prolia · RYBELSUS · Repatha · Rybelsus · SOLIQUA 100/33 · SOMAVERT · SYNJARDY · Saxenda · TEPEZZA · TOUJEO · TRADJENTA · TRULICITY · Tirosint · Tresiba · Tymlos · Vascepa · Veozah · Victoza · XARELTO · XIFAXAN · t-slim insulin pump · t:slim X2 Insulin Pump with Control-IQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $480 per 100 Medicare services performed
Looking for an endocrinology specialist in Odessa?
Compare endocrinologists in the Odessa area by procedure volume, costs, and industry payment transparency.
Browse endocrinologists nearby

Geographic Context

Endocrinologists within 10 mi
6
Per 100K population
3.7
County median income
$71,031
Nearest hospital
MEDICAL CENTER HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Nargunan is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement, with 17 years of NPI registration.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Nargunan experienced with blood glucose (sugar) test performed by hand-held instrument?
Based on Medicare claims data, Dr. Nargunan performed 398 blood glucose (sugar) test performed by hand-held instrument services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Nargunan receive payments from pharmaceutical companies?
Yes. Dr. Nargunan received a total of $6,926 from 38 companies across 348 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Nargunan's costs compare to other endocrinologists in Odessa?
Dr. Nargunan's average Medicare payment per service is $39. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Nargunan) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →